Catalyst Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Catalyst Wealth Management's MDT Position: Q1 2023 in Review
Catalyst Wealth Management increased its Medtronic (MDT) stake by 9% in Q1 2023, buying an estimated $91K and bringing the position to 13,479 shares worth $1.09M. The position accounts for 1.02% of the portfolio, ranked #40.
Catalyst Wealth Management first reported a position in MDT in Q4 2022 and has held it in 2 quarters since. 1,992 funds tracked by Wall St. Rank hold MDT as of Q1 2023.
- Catalyst Wealth Management held 13,479 shares of Medtronic worth $1.09M as of Q1 2023.
- Catalyst Wealth Management bought 1,116 Medtronic shares in Q1 2023, an estimated $91K.
- Medtronic made up 1.02% of Catalyst Wealth Management's portfolio in Q1 2023, its #40 holding.
- Catalyst Wealth Management first reported a position in Medtronic in Q4 2022 and has held it in 2 quarters since.
- 1,992 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.
Based on Catalyst Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.